Prilenia: Prilenia Therapeutics B.V.: Prilenia's Pridopidine for Huntington's Disease Accepted for European Marketing Authorisation Review

Pridopidine's Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) is the first submission for approval for an investigational new treatment for adults with Huntington'...